Tarsus Pharmaceuticals Ownership 2024 | Who Owns Tarsus Pharmaceuticals Now?
Institutional Ownership
122.41%
Insider Ownership
8.66%
Retail Ownership
-31.07%
Institutional Holders
161.00
Tarsus Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 10.24% | 1.76% | 3,272,341 | 120,000 | 3.81% | 118,949,595 | Mar 31, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 8.96% | 3.66% | 2,863,406 | 1,838,406 | 179.36% | 104,084,808 | Mar 31, 2024 |
| BLACKROCK INC. | 8.30% | 0.00% | 2,652,680 | 136,541 | 5.43% | 96,424,917 | Mar 31, 2024 |
| MORGAN STANLEY | 7.51% | 0.01% | 2,398,918 | 441,230 | 22.54% | 87,200,670 | Mar 31, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 7.06% | 8.53% | 2,254,797 | 50,000 | 2.27% | 81,961,871 | Mar 31, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 6.70% | 3.41% | 2,139,102 | -82,320 | -3.71% | 77,756,358 | Mar 31, 2024 |
| COWEN AND COMPANY, LLC | 6.64% | 2.99% | 2,122,530 | 211,131 | 11.05% | 77,153,965 | Mar 31, 2024 |
| VANGUARD GROUP INC | 5.72% | 0.00% | 1,826,632 | 231,131 | 14.49% | 66,398,072 | Mar 31, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 5.60% | 2.74% | 1,787,527 | - | - | 64,976,606 | Mar 31, 2024 |
| JENNISON ASSOCIATES LLC | 4.17% | 0.03% | 1,330,938 | 1,330,938 | 100.00% | 48,379,596 | Mar 31, 2024 |
| PERCEPTIVE ADVISORS LLC | 4.06% | 0.82% | 1,296,416 | - | - | 47,124,722 | Mar 31, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 2.81% | 0.11% | 898,000 | 824,000 | 1113.51% | 32,642,300 | Mar 31, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 2.48% | 2.28% | 793,829 | -349,028 | -30.54% | 28,855,684 | Mar 31, 2024 |
| ENSIGN PEAK ADVISORS, INC | 2.28% | 0.05% | 727,891 | 290,000 | 66.23% | 26,458,838 | Mar 31, 2024 |
| STATE STREET CORP | 2.24% | 0.00% | 717,090 | 42,259 | 6.26% | 26,066,222 | Mar 31, 2024 |
| IKARIAN CAPITAL, LLC | 2.22% | 2.82% | 710,277 | 191,758 | 36.98% | 25,818,568 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.97% | 0.00% | 629,692 | 19,956 | 3.27% | 22,892,539 | Mar 31, 2024 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 1.96% | 0.03% | 627,430 | 237,419 | 60.87% | 22,807,081 | Mar 31, 2024 |
| BOONE CAPITAL MANAGEMENT LLC | 1.91% | 4.48% | 609,104 | 609,104 | 100.00% | 22,140,930 | Mar 31, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 1.85% | 1.99% | 590,000 | 490,000 | 490.00% | 21,446,500 | Mar 31, 2024 |
Tarsus Pharmaceuticals's largest institutional shareholder is RTW INVESTMENTS, LP, holding 10.24% of the company's total share outstanding, currently valued at $118.95M. The top 10 institutional shareholders own together 70.90% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 7.06% | 8.53% | 2,254,797 | 50,000 | 2.27% | 81,961,871 | Mar 31, 2024 |
| BOONE CAPITAL MANAGEMENT LLC | 1.91% | 4.48% | 609,104 | 609,104 | 100.00% | 22,140,930 | Mar 31, 2024 |
| TFG ASSET MANAGEMENT GP LTD | 1.41% | 3.71% | 450,000 | -350,000 | -43.75% | 16,357,500 | Mar 31, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 8.96% | 3.66% | 2,863,406 | 1,838,406 | 179.36% | 104,084,808 | Mar 31, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 6.70% | 3.41% | 2,139,102 | -82,320 | -3.71% | 77,756,358 | Mar 31, 2024 |
| GHOST TREE CAPITAL, LLC | 0.94% | 3.02% | 300,000 | - | - | 10,905,000 | Mar 31, 2024 |
| COWEN AND COMPANY, LLC | 6.64% | 2.99% | 2,122,530 | 211,131 | 11.05% | 77,153,965 | Mar 31, 2024 |
| IKARIAN CAPITAL, LLC | 2.22% | 2.82% | 710,277 | 191,758 | 36.98% | 25,818,568 | Mar 31, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 5.60% | 2.74% | 1,787,527 | - | - | 64,976,606 | Mar 31, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 2.48% | 2.28% | 793,829 | -349,028 | -30.54% | 28,855,684 | Mar 31, 2024 |
| STEMPOINT CAPITAL LP | 0.70% | 2.14% | 222,253 | 191,263 | 617.18% | 8,078,897 | Mar 31, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.21% | 2.06% | 66,300 | -18,100 | -21.45% | 2,410,005 | Mar 31, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 1.85% | 1.99% | 590,000 | 490,000 | 490.00% | 21,446,500 | Mar 31, 2024 |
| RTW INVESTMENTS, LP | 10.24% | 1.76% | 3,272,341 | 120,000 | 3.81% | 118,949,595 | Mar 31, 2024 |
| VIVO CAPITAL, LLC | 1.77% | 1.62% | 565,550 | -1,218,456 | -68.30% | 20,557,743 | Mar 31, 2024 |
| SANDS CAPITAL VENTURES, LLC | 0.53% | 1.49% | 170,000 | -90,000 | -34.62% | 6,179,500 | Mar 31, 2024 |
| GRANT/GROSSMENDELSOHN, LLC | 0.17% | 0.91% | 53,610 | - | - | 1,943,899 | Mar 31, 2024 |
| PERCEPTIVE ADVISORS LLC | 4.06% | 0.82% | 1,296,416 | - | - | 47,124,722 | Mar 31, 2024 |
| EAM INVESTORS, LLC | 0.32% | 0.57% | 100,658 | 100,658 | 100.00% | 3,658,918 | Mar 31, 2024 |
| IKARIAN CAPITAL, LLC | 0.31% | 0.40% | 100,000 | - | - | 3,635,000 | Mar 31, 2024 |
The largest Tarsus Pharmaceuticals shareholder by % of total assets is TANG CAPITAL MANAGEMENT LLC. The company owns 2.25M shares of Tarsus Pharmaceuticals (TARS), representing 8.53% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PARADIGM BIOCAPITAL ADVISORS LP | 8.96% | 3.66% | 2,863,406 | 1,838,406 | 179.36% | 104,084,808 | Mar 31, 2024 |
| JENNISON ASSOCIATES LLC | 4.17% | 0.03% | 1,330,938 | 1,330,938 | 100.00% | 48,379,596 | Mar 31, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 2.81% | 0.11% | 898,000 | 824,000 | 1113.51% | 32,642,300 | Mar 31, 2024 |
| BOONE CAPITAL MANAGEMENT LLC | 1.91% | 4.48% | 609,104 | 609,104 | 100.00% | 22,140,930 | Mar 31, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 1.85% | 1.99% | 590,000 | 490,000 | 490.00% | 21,446,500 | Mar 31, 2024 |
| MORGAN STANLEY | 7.51% | 0.01% | 2,398,918 | 441,230 | 22.54% | 87,200,670 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.09% | 0.00% | 347,683 | 347,683 | 100.00% | 12,640,000 | Mar 31, 2024 |
| ENSIGN PEAK ADVISORS, INC | 2.28% | 0.05% | 727,891 | 290,000 | 66.23% | 26,458,838 | Mar 31, 2024 |
| WALLEYE CAPITAL LLC | 0.85% | 0.02% | 272,498 | 272,498 | 100.00% | 9,905,302 | Mar 31, 2024 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 1.96% | 0.03% | 627,430 | 237,419 | 60.87% | 22,807,081 | Mar 31, 2024 |
| VANGUARD GROUP INC | 5.72% | 0.00% | 1,826,632 | 231,131 | 14.49% | 66,398,072 | Mar 31, 2024 |
| COWEN AND COMPANY, LLC | 6.64% | 2.99% | 2,122,530 | 211,131 | 11.05% | 77,153,965 | Mar 31, 2024 |
| IKARIAN CAPITAL, LLC | 2.22% | 2.82% | 710,277 | 191,758 | 36.98% | 25,818,568 | Mar 31, 2024 |
| STEMPOINT CAPITAL LP | 0.70% | 2.14% | 222,253 | 191,263 | 617.18% | 8,078,897 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.69% | 0.00% | 219,278 | 176,241 | 409.51% | 7,970,755 | Mar 31, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0.50% | 0.06% | 161,163 | 161,163 | 100.00% | 5,858,275 | Mar 31, 2024 |
| D. E. SHAW & CO., INC. | 0.62% | 0.01% | 196,512 | 155,985 | 384.89% | 7,143,211 | Mar 31, 2024 |
| CIBC WORLD MARKET INC. | 0.47% | 0.01% | 150,000 | 150,000 | 100.00% | 5,452,000 | Mar 31, 2024 |
| CIBC WORLD MARKETS CORP | 0.47% | 0.04% | 150,000 | 150,000 | 100.00% | 5,452,500 | Mar 31, 2024 |
| BLACKROCK INC. | 8.30% | 0.00% | 2,652,680 | 136,541 | 5.43% | 96,424,917 | Mar 31, 2024 |
As of Mar 31 2024, Tarsus Pharmaceuticals's largest institutional buyer is PARADIGM BIOCAPITAL ADVISORS LP. The company purchased 1.84M stocks of TARS, valued at $104.08M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VIVO CAPITAL, LLC | 1.77% | 1.62% | 565,550 | -1,218,456 | -68.30% | 20,557,743 | Mar 31, 2024 |
| TFG ASSET MANAGEMENT GP LTD | 1.41% | 3.71% | 450,000 | -350,000 | -43.75% | 16,357,500 | Mar 31, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 2.48% | 2.28% | 793,829 | -349,028 | -30.54% | 28,855,684 | Mar 31, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 0.47% | 0.31% | 150,321 | -224,955 | -59.94% | 5,464,168 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.08% | 0.00% | 25,644 | -172,810 | -87.08% | 932,159 | Mar 31, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.05% | 0.00% | 15,531 | -163,983 | -91.35% | 564,551 | Mar 31, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | 0.85% | 0.09% | 270,758 | -110,000 | -28.89% | 9,842,053 | Mar 31, 2024 |
| SANDS CAPITAL VENTURES, LLC | 0.53% | 1.49% | 170,000 | -90,000 | -34.62% | 6,179,500 | Mar 31, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 6.70% | 3.41% | 2,139,102 | -82,320 | -3.71% | 77,756,358 | Mar 31, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.49% | 0.00% | 156,787 | -79,655 | -33.69% | 5,699,208 | Mar 31, 2024 |
| SG AMERICAS SECURITIES, LLC | 0.03% | 0.00% | 10,674 | -44,305 | -80.59% | 388,000 | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 0.64% | 0.00% | 203,730 | -33,709 | -14.20% | 7,405,586 | Mar 31, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -19,575 | -100.00% | - | Mar 31, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.21% | 2.06% | 66,300 | -18,100 | -21.45% | 2,410,005 | Mar 31, 2024 |
| BARCLAYS PLC | 0.09% | 0.00% | 30,308 | -16,951 | -35.87% | 1,101,000 | Mar 31, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.68% | 0.06% | 215,958 | -16,942 | -7.27% | 7,850,000 | Mar 31, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | - | - | - | -15,400 | -100.00% | - | Mar 31, 2024 |
| OPPENHEIMER & CO INC | - | - | - | -14,056 | -100.00% | - | Mar 31, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.02% | 0.02% | 5,738 | -13,228 | -69.75% | 209,000 | Mar 31, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -11,226 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Tarsus Pharmaceuticals's biggest institutional seller is VIVO CAPITAL, LLC. The company sold -1.22M shares of TARS, valued at $20.56M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JENNISON ASSOCIATES LLC | 4.17% | 0.03% | 1,330,938 | 1,330,938 | 100.00% | 48,379,596 | Mar 31, 2024 |
| BOONE CAPITAL MANAGEMENT LLC | 1.91% | 4.48% | 609,104 | 609,104 | 100.00% | 22,140,930 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.09% | 0.00% | 347,683 | 347,683 | 100.00% | 12,640,000 | Mar 31, 2024 |
| WALLEYE CAPITAL LLC | 0.85% | 0.02% | 272,498 | 272,498 | 100.00% | 9,905,302 | Mar 31, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0.50% | 0.06% | 161,163 | 161,163 | 100.00% | 5,858,275 | Mar 31, 2024 |
| CIBC WORLD MARKET INC. | 0.47% | 0.01% | 150,000 | 150,000 | 100.00% | 5,452,000 | Mar 31, 2024 |
| BAIRD FINANCIAL GROUP, INC. | 0.40% | 0.01% | 128,272 | 128,272 | 100.00% | 4,662,687 | Mar 31, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.35% | 0.00% | 111,422 | 111,422 | 100.00% | 4,050,189 | Mar 31, 2024 |
| EAM INVESTORS, LLC | 0.32% | 0.57% | 100,658 | 100,658 | 100.00% | 3,658,918 | Mar 31, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 0.31% | 0.03% | 100,000 | 100,000 | 100.00% | 3,635,000 | Mar 31, 2024 |
| LORD, ABBETT & CO. LLC | 0.26% | 0.01% | 82,226 | 82,226 | 100.00% | 2,989,000 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.19% | 0.00% | 60,994 | 60,994 | 100.00% | 2,217,132 | Mar 31, 2024 |
| STEMPOINT CAPITAL LP | 0.16% | 0.01% | 50,000 | 50,000 | 100.00% | 41,250 | Mar 31, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | 0.16% | 0.21% | 50,000 | 50,000 | 100.00% | 1,817,500 | Mar 31, 2024 |
| TD ASSET MANAGEMENT INC | 0.15% | 0.00% | 48,588 | 48,588 | 100.00% | 1,766,174 | Mar 31, 2024 |
| JACKSON CREEK INVESTMENT ADVISORS LLC | 0.09% | 0.38% | 29,577 | 29,577 | 100.00% | 1,075,000 | Mar 31, 2024 |
| JUMP FINANCIAL, LLC | 0.09% | 0.03% | 29,470 | 29,470 | 100.00% | 1,071,235 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.08% | 0.00% | 25,300 | 25,300 | 100.00% | 919,655 | Mar 31, 2024 |
| E. OHMAN J:OR ASSET MANAGEMENT AB | 0.08% | 0.02% | 25,000 | 25,000 | 100.00% | 908,750 | Mar 31, 2024 |
| CITIGROUP INC | 0.07% | 0.00% | 23,000 | 23,000 | 100.00% | 836,050 | Mar 31, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.07% | 0.00% | 22,720 | 22,720 | 100.00% | 825,872 | Mar 31, 2024 |
| THOROUGHBRED FINANCIAL SERVICES, LLC | 0.07% | 0.07% | 20,964 | 20,964 | 100.00% | 762,000 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.05% | 0.00% | 17,400 | 17,400 | 100.00% | 632,490 | Mar 31, 2024 |
| FEDERATED HERMES, INC. | 0.05% | 0.00% | 15,465 | 15,465 | 100.00% | 562,153 | Mar 31, 2024 |
| ALPHA DNA INVESTMENT MANAGEMENT LLC | 0.04% | 0.19% | 13,913 | 13,913 | 100.00% | 505,738 | Mar 31, 2024 |
| HARBOR CAPITAL ADVISORS, INC. | 0.04% | 0.06% | 11,620 | 11,620 | 100.00% | 422,000 | Mar 31, 2024 |
| QUANTBOT TECHNOLOGIES LP | 0.04% | 0.02% | 11,266 | 11,266 | 100.00% | 409,519 | Mar 31, 2024 |
| ENVESTNET ASSET MANAGEMENT INC | 0.04% | 0.00% | 11,229 | 11,229 | 100.00% | 408,174 | Mar 31, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | 0.03% | 0.00% | 10,537 | 10,537 | 100.00% | 383,020 | Mar 31, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.03% | 0.00% | 10,195 | 10,195 | 100.00% | 370,588 | Mar 31, 2024 |
| CALAMOS ADVISORS LLC | 0.03% | 0.00% | 9,878 | 9,878 | 100.00% | 359,065 | Mar 31, 2024 |
| JANUS HENDERSON GROUP PLC | 0.03% | 0.00% | 8,596 | 8,596 | 100.00% | 312,974 | Mar 31, 2024 |
| PROSHARE ADVISORS LLC | 0.02% | 0.00% | 7,631 | 7,631 | 100.00% | 277,387 | Mar 31, 2024 |
| PROFUND ADVISORS LLC | 0.02% | 0.01% | 7,197 | 7,197 | 100.00% | 261,611 | Mar 31, 2024 |
| CREATIVE PLANNING | 0.02% | 0.00% | 6,595 | 6,595 | 100.00% | 239,728 | Mar 31, 2024 |
| BLEAKLEY FINANCIAL GROUP, LLC | 0.02% | 0.01% | 6,147 | 6,147 | 100.00% | 223,443 | Mar 31, 2024 |
| SIMPLICITY WEALTH,LLC | 0.02% | 0.01% | 6,133 | 6,133 | 100.00% | 222,935 | Mar 31, 2024 |
| NATIONS FINANCIAL GROUP INC, /IA/ /ADV | 0.02% | 0.02% | 6,000 | 6,000 | 100.00% | 218,100 | Mar 31, 2024 |
| ARIZONA STATE RETIREMENT SYSTEM | 0.02% | 0.00% | 5,914 | 5,914 | 100.00% | 214,974 | Mar 31, 2024 |
| BELVEDERE TRADING LLC | 0.02% | 0.00% | 5,900 | 5,900 | 100.00% | 214,465 | Mar 31, 2024 |
| KEYBANK NATIONAL ASSOCIATION/OH | 0.02% | 0.00% | 5,729 | 5,729 | 100.00% | 208,249 | Mar 31, 2024 |
| BELVEDERE TRADING LLC | 0.01% | 0.00% | 4,709 | 4,709 | 100.00% | 171,172 | Mar 31, 2024 |
| BELVEDERE TRADING LLC | 0.01% | 0.00% | 3,200 | 3,200 | 100.00% | 116,320 | Mar 31, 2024 |
| NVERSES CAPITAL, LLC | 0.01% | 0.17% | 1,900 | 1,900 | 100.00% | 69,065,000 | Mar 31, 2024 |
| MACROVIEW INVESTMENT MANAGEMENT LLC | 0.00% | 0.01% | 224 | 224 | 100.00% | 8,143 | Mar 31, 2024 |
| ALLWORTH FINANCIAL LP | 0.00% | - | 21 | 21 | 100.00% | 764,000 | Mar 31, 2024 |
| RIGGS ASSET MANAGMENT CO. INC. | - | 0.00% | 10 | 10 | 100.00% | 364 | Mar 31, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | 5 | 5 | 100.00% | 181 | Mar 31, 2024 |
Tarsus Pharmaceuticals's largest new institutional shareholder by number of shares is JENNISON ASSOCIATES LLC, purchased 1.33M shares, valued at $48.38M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -19,575 | -100.00% | - | Mar 31, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | - | - | - | -15,400 | -100.00% | - | Mar 31, 2024 |
| OPPENHEIMER & CO INC | - | - | - | -14,056 | -100.00% | - | Mar 31, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -11,226 | -100.00% | - | Mar 31, 2024 |
| AMERICAN CENTURY COMPANIES INC | - | - | - | -11,075 | -100.00% | - | Mar 31, 2024 |
| COMERICA BANK | - | - | - | -57 | -100.00% | - | Mar 31, 2024 |
Tarsus Pharmaceuticals's largest sold out institutional shareholder by shares sold is POINT72 ASSET MANAGEMENT, L.P., sold -19.57K shares, valued at -, as of undefined.
Tarsus Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| AMG FUNDS | 1.21% | 134,950 | - | - | Jan 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.14% | 150,000 | - | - | Dec 29, 2023 |
| TEKLA LIFE SCIENCES INVESTORS | 0.13% | 72,032 | 24,652 | 52.03% | Dec 31, 2023 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.12% | 248,855 | 248,855 | - | Feb 29, 2024 |
| ALLSPRING VARIABLE TRUST | 0.11% | 58,800 | 1,200 | 2.08% | Dec 31, 2023 |
| VANGUARD VALLEY FORGE FUNDS | 0.04% | 20,360 | - | - | Dec 31, 2023 |
| ETFis Series Trust I | 0.01% | 17,061 | 11,053 | 183.97% | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 4,356 | 707 | 19.38% | Dec 31, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 43,606 | 2,637 | 6.44% | Dec 31, 2023 |
| VANGUARD INDEX FUNDS | 0.00% | 1,740,255 | 437,459 | 33.58% | Dec 31, 2023 |
| Nushares ETF Trust | 0.00% | 25,511 | -2,256 | -8.12% | Jan 31, 2024 |
| Humankind Benefit Corp | 0.00% | 59 | - | - | Dec 31, 2023 |
| ALPS ETF Trust | 0.00% | 23,605 | 564 | 2.45% | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 256,518 | 10,655 | 4.33% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,970 | 1,023 | 52.54% | Dec 31, 2023 |
| ALLSPRING MASTER TRUST | 0.00% | 61,566 | -3,434 | -5.28% | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 197 | - | - | Dec 31, 2023 |
| SCHWAB STRATEGIC TRUST | 0.00% | 141,562 | 8,354 | 6.27% | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 20,054 | - | - | Dec 31, 2023 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 1,854 | - | - | Feb 29, 2024 |
| OLD WESTBURY FUNDS INC | 0.00% | 71,191 | 10,354 | 17.02% | Jan 31, 2024 |
| AdvisorShares Trust | 0.00% | 1,289 | - | - | Dec 29, 2023 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 31,636 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 11,442 | 1,679 | 17.20% | Dec 31, 2023 |
| Principal Exchange-Traded Funds | 0.00% | 4,417 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 354,886 | 115,401 | 48.19% | Jan 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 72,043 | -5,498 | -7.09% | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 775 | - | - | Dec 31, 2023 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,282 | - | - | Dec 31, 2023 |
| ARTISAN PARTNERS FUNDS INC | 0.00% | 245,969 | - | - | Dec 31, 2023 |
| Dimensional ETF Trust | 0.00% | 94,104 | 29,960 | 46.71% | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 10,943 | 10,509 | 2421.43% | Feb 29, 2024 |
| ProFunds | 0.00% | 1,660 | -3,686 | -68.95% | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 11,000 | 4,100 | 59.42% | Dec 31, 2023 |
| RBB FUND, INC. | 0.00% | 11,528 | 9,726 | 539.73% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,435 | -48 | -3.24% | Dec 31, 2023 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 11,043 | 656 | 6.32% | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,682 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 126,027 | 33,507 | 36.22% | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 70,104 | 6,245 | 9.78% | Dec 31, 2023 |
| Goldman Sachs ETF Trust | 0.00% | 5,194 | 5,194 | - | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 215 | - | - | Dec 31, 2023 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 57,168 | 47,772 | 508.43% | Dec 31, 2023 |
| VANGUARD WELLINGTON FUND | 0.00% | 16,036 | 16,036 | - | Feb 29, 2024 |
| VALIC Co I | 0.00% | 11,012 | 1,927 | 21.21% | Feb 29, 2024 |
| Direxion Shares ETF Trust | 0.00% | 5,075 | 2,057 | 68.16% | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 4,453 | -17,301 | -79.53% | Dec 31, 2023 |
| PROSHARES TRUST | 0.00% | 6,677 | 1,555 | 30.36% | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 107 | - | - | Dec 31, 2023 |
| PENN SERIES FUNDS INC | 0.00% | 700 | - | - | Dec 29, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 2,769 | 124 | 4.69% | Jan 31, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 4,143 | - | - | Feb 29, 2024 |
| PGIM ETF TRUST | 0.00% | 1,113 | - | - | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 12,641 | 2,062 | 19.49% | Dec 29, 2023 |
| RYDEX VARIABLE TRUST | 0.00% | 14 | - | - | Dec 31, 2023 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,170 | 343 | 41.48% | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 21,862 | 900 | 4.29% | Dec 31, 2023 |
| SUNAMERICA SERIES TRUST | 0.00% | 3,251 | 569 | 21.22% | Jan 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 50 | - | - | Feb 29, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 527 | - | - | Dec 31, 2023 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 11,300 | 1,613 | 16.65% | Dec 31, 2023 |
| Brighthouse Funds Trust II | 0.00% | 9,885 | 1,764 | 21.72% | Dec 31, 2023 |
| PACIFIC SELECT FUND | 0.00% | 11,801 | 1,862 | 18.73% | Dec 31, 2023 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 15,875 | - | - | Feb 29, 2024 |
| AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS) | 0.00% | 7,498 | 7,498 | - | Dec 31, 2023 |
| SPDR SERIES TRUST | 0.00% | 112,472 | 28,365 | 33.72% | Dec 31, 2023 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 867 | 303 | 53.72% | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 40,005 | -1,264,955 | -96.93% | Feb 29, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 300 | 300 | - | Dec 31, 2023 |
| Advisors' Inner Circle Fund III | 0.00% | 33 | - | - | Jan 31, 2024 |
| Bridge Builder Trust | 0.00% | 11,910 | 2,122 | 21.68% | Dec 31, 2023 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 3,582 | 748 | 26.39% | Dec 31, 2023 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 16,733 | 14,133 | 543.58% | Feb 29, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 626 | - | - | Dec 31, 2023 |
Tarsus Pharmaceuticals's largest mutual fund holder by % of total assets is "AMG FUNDS", owning 134.95K shares, compromising 1.21% of its total assets.
Tarsus Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 161 | 35.29% |
| 31 Dec, 23 | 119 | 11.21% |
| 30 Sep, 23 | 107 | 15.05% |
| 30 Jun, 23 | 93 | 22.37% |
| 31 Mar, 23 | 76 | 5.56% |
| 31 Dec, 22 | 72 | -1.37% |
| 30 Sep, 22 | 73 | 1.39% |
| 30 Jun, 22 | 72 | 41.18% |
| 31 Mar, 22 | 51 | 18.60% |
| 31 Dec, 21 | 43 | -2.27% |
| 30 Sep, 21 | 44 | - |
| 30 Jun, 21 | 44 | 7.32% |
| 31 Mar, 21 | 41 | 2.50% |
| 31 Dec, 20 | 40 | - |
As of 31 Mar 24, 161 institutions are holding Tarsus Pharmaceuticals's shares, representing an increase of 35.29% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 39,102,983 | 21.86% |
| 31 Dec, 23 | 32,089,068 | 7.71% |
| 30 Sep, 23 | 29,793,106 | 39.20% |
| 30 Jun, 23 | 21,403,247 | 6.71% |
| 31 Mar, 23 | 20,057,975 | -2.75% |
| 31 Dec, 22 | 20,624,782 | 0.73% |
| 30 Sep, 22 | 20,474,884 | 2.47% |
| 30 Jun, 22 | 19,981,073 | 51.25% |
| 31 Mar, 22 | 13,210,424 | 1.05% |
| 31 Dec, 21 | 13,073,070 | 1.58% |
| 30 Sep, 21 | 12,869,550 | -1.47% |
| 30 Jun, 21 | 13,061,736 | 2.35% |
| 31 Mar, 21 | 12,761,893 | 0.02% |
| 31 Dec, 20 | 12,759,603 | - |
Tarsus Pharmaceuticals (TARS) has 39.10M shares outstanding as of 31 Mar 24, up 21.86% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 122.41% | 1.11% |
| 31 Dec, 23 | 104.79% | 0.85% |
| 30 Sep, 23 | 111.10% | 1.73% |
| 30 Jun, 23 | 80.04% | 1.42% |
| 31 Mar, 23 | 75.01% | 1.07% |
| 31 Dec, 22 | 83.77% | 1.42% |
| 30 Sep, 22 | 76.79% | 1.14% |
| 30 Jun, 22 | 82.12% | 2.02% |
| 31 Mar, 22 | 63.79% | 1.59% |
| 31 Dec, 21 | 63.33% | 1.63% |
| 30 Sep, 21 | 62.35% | 1.54% |
| 30 Jun, 21 | 63.54% | 1.61% |
| 31 Mar, 21 | 62.76% | 1.59% |
| 31 Dec, 20 | 62.74% | - |
As of 31 Mar 24, Tarsus Pharmaceuticals is held by 122.41% institutional shareholders, representing a 1.11% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 102 | 36.00% |
| 31 Dec, 23 | 75 | 1.35% |
| 30 Sep, 23 | 74 | 19.35% |
| 30 Jun, 23 | 62 | 67.57% |
| 31 Mar, 23 | 37 | - |
| 31 Dec, 22 | 37 | 5.71% |
| 30 Sep, 22 | 35 | -33.96% |
| 30 Jun, 22 | 53 | 165.00% |
| 31 Mar, 22 | 20 | 5.26% |
| 31 Dec, 21 | 19 | 18.75% |
| 30 Sep, 21 | 16 | -40.74% |
| 30 Jun, 21 | 27 | 58.82% |
| 31 Mar, 21 | 17 | -57.50% |
| 31 Dec, 20 | 40 | - |
102 institutional shareholders have increased their position in TARS stock as of 31 Mar 24 compared to 75 in the previous quarter (a 36.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 31 | 29.17% |
| 31 Dec, 23 | 24 | 84.62% |
| 30 Sep, 23 | 13 | -7.14% |
| 30 Jun, 23 | 14 | -30.00% |
| 31 Mar, 23 | 20 | 5.26% |
| 31 Dec, 22 | 19 | -5.00% |
| 30 Sep, 22 | 20 | 150.00% |
| 30 Jun, 22 | 8 | -57.89% |
| 31 Mar, 22 | 19 | 137.50% |
| 31 Dec, 21 | 8 | -50.00% |
| 30 Sep, 21 | 16 | 77.78% |
| 30 Jun, 21 | 9 | -25.00% |
| 31 Mar, 21 | 12 | - |
| 31 Dec, 20 | - | - |
31 institutional shareholders have reduced their position in TARS stock as of 31 Mar 24 compared to 24 in the previous quarter (a 29.17% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 161 | 35.29% | 39,102,983 | 21.86% | 122.41% | 1.11% | 102 | 36.00% | 31 | 29.17% |
| 31 Dec, 23 | 119 | 11.21% | 32,089,068 | 7.71% | 104.79% | 0.85% | 75 | 1.35% | 24 | 84.62% |
| 30 Sep, 23 | 107 | 15.05% | 29,793,106 | 39.20% | 111.10% | 1.73% | 74 | 19.35% | 13 | -7.14% |
| 30 Jun, 23 | 93 | 22.37% | 21,403,247 | 6.71% | 80.04% | 1.42% | 62 | 67.57% | 14 | -30.00% |
| 31 Mar, 23 | 76 | 5.56% | 20,057,975 | -2.75% | 75.01% | 1.07% | 37 | - | 20 | 5.26% |
| 31 Dec, 22 | 72 | -1.37% | 20,624,782 | 0.73% | 83.77% | 1.42% | 37 | 5.71% | 19 | -5.00% |
| 30 Sep, 22 | 73 | 1.39% | 20,474,884 | 2.47% | 76.79% | 1.14% | 35 | -33.96% | 20 | 150.00% |
| 30 Jun, 22 | 72 | 41.18% | 19,981,073 | 51.25% | 82.12% | 2.02% | 53 | 165.00% | 8 | -57.89% |
| 31 Mar, 22 | 51 | 18.60% | 13,210,424 | 1.05% | 63.79% | 1.59% | 20 | 5.26% | 19 | 137.50% |
| 31 Dec, 21 | 43 | -2.27% | 13,073,070 | 1.58% | 63.33% | 1.63% | 19 | 18.75% | 8 | -50.00% |
| 30 Sep, 21 | 44 | - | 12,869,550 | -1.47% | 62.35% | 1.54% | 16 | -40.74% | 16 | 77.78% |
| 30 Jun, 21 | 44 | 7.32% | 13,061,736 | 2.35% | 63.54% | 1.61% | 27 | 58.82% | 9 | -25.00% |
| 31 Mar, 21 | 41 | 2.50% | 12,761,893 | 0.02% | 62.76% | 1.59% | 17 | -57.50% | 12 | - |
| 31 Dec, 20 | 40 | - | 12,759,603 | - | 62.74% | - | 40 | - | - | - |
Tarsus Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Tarsus Pharmaceuticals's stock was made by Mottiwala Aziz on Mar 19 2024, selling 4,766 shares at $30.60 per share (valued at $145.84K).
Tarsus Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 18 | 15 | 120.00% |
| Q4 2023 | 4 | 14 | 28.57% |
| Q3 2023 | 2 | 7 | 28.57% |
| Q2 2023 | 23 | 21 | 109.52% |
| Q1 2023 | 23 | 69 | 33.33% |
| Q4 2022 | 6 | 24 | 25.00% |
| Q3 2022 | 4 | 8 | 50.00% |
| Q2 2022 | 18 | 7 | 257.14% |
| Q1 2022 | 17 | - | - |
| Q4 2021 | 2 | 27 | 7.41% |
| Q3 2021 | 3 | 18 | 16.67% |
| Q2 2021 | 9 | 7 | 128.57% |
| Q1 2021 | 7 | 1 | 700.00% |
| Q4 2020 | 26 | 45 | 57.78% |
18 total buy trades, and 15 total sell trades (buy/sell ratio of 1.20%) were made by Tarsus Pharmaceuticals's insiders, as of Q1 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | - | 5 | - |
| Q4 2023 | 1 | 11 | 9.09% |
| Q3 2023 | 1 | 6 | 16.67% |
| Q2 2023 | - | 13 | - |
| Q1 2023 | - | 60 | - |
| Q4 2022 | - | 21 | - |
| Q3 2022 | 2 | 7 | 28.57% |
| Q2 2022 | 1 | 6 | 16.67% |
| Q1 2022 | - | - | - |
| Q4 2021 | - | 23 | - |
| Q3 2021 | - | 16 | - |
| Q2 2021 | - | 7 | - |
| Q1 2021 | - | - | - |
| Q4 2020 | 6 | - | - |
As of Q1 2024, Insider owners conducted 0 open market buy trades and 5 open market sell trades of Tarsus Pharmaceuticals's stocks.
Tarsus Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| DSGN | Design Therapeutics, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| TYRA | Tyra Biosciences, Inc. |
| PEPG | PepGen Inc. |
| NUVL | Nuvalent, Inc. |
| TVTX | Travere Therapeutics, Inc. |
| NUVB | Nuvation Bio Inc. |
| STOK | Stoke Therapeutics, Inc. |
| GNFT | Genfit S.A. |
| TRDA | Entrada Therapeutics, Inc. |
| ELDN | Eledon Pharmaceuticals, Inc. |
| HOWL | Werewolf Therapeutics, Inc. |
| LIAN | LianBio |
| CNTA | Centessa Pharmaceuticals plc |
| GLUE | Monte Rosa Therapeutics, Inc. |
| ETON | Eton Pharmaceuticals, Inc. |
| PHVS | Pharvaris N.V. |
| ALDX | Aldeyra Therapeutics, Inc. |
| CNTB | Connect Biopharma Holdings Limited |
| IKNA | Ikena Oncology, Inc. |
| RLYB | Rallybio Corporation |
| OPT | Opthea Limited |
TARS Ownership FAQ
Who Owns Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals is owned by institutional shareholders (122.41%), insiders (8.66%), and public (-31.07%). The largest institutional shareholder of Tarsus Pharmaceuticals is RTW INVESTMENTS, LP (10.24% of total shares) and the top mutual fund owner is AMG FUNDS (1.21% of total shares).
Who are the major institutional shareholders of Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals's major institutional shareholders are RTW INVESTMENTS, LP, PARADIGM BIOCAPITAL ADVISORS LP, BLACKROCK INC., MORGAN STANLEY, and TANG CAPITAL MANAGEMENT LLC. The top five shareholders own together 42.08% of the company's share outstanding.
How many Tarsus Pharmaceuticals shareholders are there?
As of Mar 2024, there are 161 institutional shareholders of Tarsus Pharmaceuticals.
What percentage of Tarsus Pharmaceuticals is owned by RTW INVESTMENTS, LP?
RTW INVESTMENTS, LP owns 3.27M shares of Tarsus Pharmaceuticals, representing 10.24% of the company's total shares outstanding, valued at $118.95M (as of Mar 2024).
What percentage of Tarsus Pharmaceuticals is owned by PARADIGM BIOCAPITAL ADVISORS LP?
As of Mar 2024, PARADIGM BIOCAPITAL ADVISORS LP holds 2.86M shares of Tarsus Pharmaceuticals (TARS), compromising 8.96% of the company, valued at $104.08M.
What percentage of Tarsus Pharmaceuticals is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Tarsus Pharmaceuticals. The company owns 2.65M of the company's shares outstanding (worth $96.42M).